Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.
Pons-Estel GJ, Alarcón GS, Hachuel L, Boggio G, Wojdyla D, Pascual-Ramos V, Soriano ER, Saurit V, Cavalcanti FS, Guzman RA, Guibert-Toledano M, Sauza Del Pozo MJ, Amigo MC, Alva M, Esteva-Spinetti MH, Pons-Estel BA; GLADEL.
Pons-Estel GJ, et al.
Rheumatology (Oxford). 2012 Jul;51(7):1293-8. doi: 10.1093/rheumatology/ker514. Epub 2012 Mar 2.
Rheumatology (Oxford). 2012.
PMID: 22389125
Free PMC article.